Literature DB >> 10880785

Use of prevalence and incidence measures to describe age-related prescribing of antidepressants with and without anticholinergic effects.

M E van Eijk1, P Bahri, G Dekker, R M Herings, A Porsius, J Avorn, A de Boer.   

Abstract

To evaluate whether physicians avoid prescribing highly anticholinergic antidepressants (AAD) in the elderly, a population-based retrospectively data analysis was performed using databases from a Dutch health insurance company. Data collected on approximately 240,000 persons covered the period from 1 July 1993 to 1 January 1996. The prevalence and the incidence (number of new starters) of antidepressant use was measured over 1994 and 1995. Use of AAD was proportionally higher in the elderly in terms of both prevalence and incidence rates; the ratio of starters of AAD versus starters of non-AAD in 1994 increased steadily with age (from 0.54 in the age group 20-29 to 1.15 in the age group 60-69). In 1995 these incidence ratios decreased (0.41 to 0.99, respectively); however, the decrease was higher in the younger age groups. The data indicate that in the population studied, physicians do not refrain from prescribing highly anticholinergic agents to older patients despite their potential adverse drug reactions in this age group. This study also indicates that prevalence and incidence rates can be extracted from reimbursement data and give insight into actual prescribing practices.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10880785     DOI: 10.1016/s0895-4356(99)00194-8

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  7 in total

1.  Prescription and indication trends of antidepressant drugs in the Netherlands between 1996 and 2012: a dynamic population-based study.

Authors:  Raymond Noordam; Nikkie Aarts; Katia M Verhamme; Miriam C M Sturkenboom; Bruno H Stricker; Loes E Visser
Journal:  Eur J Clin Pharmacol       Date:  2015-01-06       Impact factor: 2.953

2.  Reducing prescribing of highly anticholinergic antidepressants for elderly people: randomised trial of group versus individual academic detailing.

Authors:  M E van Eijk; J Avorn; A J Porsius; A de Boer
Journal:  BMJ       Date:  2001-03-17

3.  Factors associated with changes in antidepressant use in a community-dwelling elderly cohort: the Three-City Study.

Authors:  Agnès Soudry; Carole Dufouil; Karen Ritchie; Jean-François Dartigues; Christophe Tzourio; Annick Alpérovitch
Journal:  Eur J Clin Pharmacol       Date:  2007-10-19       Impact factor: 2.953

4.  Cognitive toxicity of drugs used in the elderly.

Authors:  L L von Moltke; D J Greenblatt; M K Romach; E M Sellers
Journal:  Dialogues Clin Neurosci       Date:  2001-09       Impact factor: 5.986

5.  Prevalence, incidence, indication, and choice of antidepressants in patients with and without chronic kidney disease: a matched cohort study in UK Clinical Practice Research Datalink.

Authors:  Masao Iwagami; Laurie A Tomlinson; Kathryn E Mansfield; Helen I McDonald; Liam Smeeth; Dorothea Nitsch
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-04-11       Impact factor: 2.890

Review 6.  Effectiveness of Interventions to Improve the Anticholinergic Prescribing Practice in Older Adults: A Systematic Review.

Authors:  Mohammed S Salahudeen; Adel Alfahmi; Anam Farooq; Mehnaz Akhtar; Sana Ajaz; Saud Alotaibi; Manal Faiz; Sheraz Ali
Journal:  J Clin Med       Date:  2022-01-28       Impact factor: 4.241

7.  Association between risk factors for injurious falls and new benzodiazepine prescribing in elderly persons.

Authors:  Gillian Bartlett; Michal Abrahamowicz; Roland Grad; Marie-Pierre Sylvestre; Robyn Tamblyn
Journal:  BMC Fam Pract       Date:  2009-01-06       Impact factor: 2.497

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.